Written Question·Department of Health and Social Care·UIN 107901
Lipoedema: Medical Treatments
Tabled: 22 January 2026
Answered: 27 January 2026
Named DayQuestion
Alison Bennett
Liberal Democrat — Mid Sussex
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential role of GLP-1 medications in reducing inflammation and pain associated with lipoedema.
Answer
Dr Zubir AhmedThe Department has not made any assessment of the potential role of GLP-1 medications in reducing inflammation and pain associated with lipoedema. Newly licensed medicines are appraised by the National Institute for Health and Care Excellence (NICE), whic...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 107901) →